• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年和 2030 年全球糖尿病医疗支出。

Global healthcare expenditure on diabetes for 2010 and 2030.

机构信息

Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

Diabetes Res Clin Pract. 2010 Mar;87(3):293-301. doi: 10.1016/j.diabres.2010.01.026. Epub 2010 Feb 19.

DOI:10.1016/j.diabres.2010.01.026
PMID:20171754
Abstract

AIMS

To estimate the global health expenditure on diabetes among people aged 20-79 years for the years 2010 and 2030.

METHODS

Country-by-country expenditures for 193 countries, expressed in United States Dollars (USD) and in International Dollars (ID), were estimated based on the country's age-sex specific diabetes prevalence and population estimates, per capita health expenditures, and health expenditure ratios per person with and without diabetes. Diabetes prevalence was estimated from studies in 91 countries. Population estimates and health expenditures were from the United Nations and the World Health Organization. The health expenditure ratios were estimated based on utilization and cost data of a large health plan in the U.S. Diabetes expenditures for the year 2030 were projected by considering future changes in demographics and urbanization.

RESULTS

The global health expenditure on diabetes is expected to total at least USD 376 billion or ID 418 billion in 2010 and USD 490 billion or ID 561 billion in 2030. Globally, 12% of the health expenditures and USD 1330 (ID 1478) per person are anticipated to be spent on diabetes in 2010. The expenditure varies by region, age group, gender, and country's income level.

CONCLUSIONS

Diabetes imposes an increasing economic burden on national health care systems worldwide. More prevention efforts are needed to reduce this burden. Meanwhile, the very low expenditures per capita in poor countries indicate that more resources are required to provide basic diabetes care in such settings.

摘要

目的

估计 20-79 岁人群糖尿病的全球卫生支出,数据为 2010 年和 2030 年。

方法

根据各国特定年龄和性别的糖尿病患病率和人口估计数、人均卫生支出以及有和无糖尿病患者的人均卫生支出比例,估算了 193 个国家的国家间支出。糖尿病患病率来自 91 个国家的研究。人口估计数和卫生支出来自联合国和世界卫生组织。根据美国一家大型医保计划的使用和成本数据估算了卫生支出比例。考虑到人口统计学和城市化的未来变化,预测了 2030 年的糖尿病支出。

结果

预计全球糖尿病卫生支出 2010 年至少将达到 3760 亿美元或 4180 亿国际元,2030 年将达到 4900 亿美元或 5610 亿国际元。全球卫生支出的 12%和每人 1330 美元(或 1478 国际元)预计将用于 2010 年的糖尿病。支出因地区、年龄组、性别和国家收入水平而异。

结论

糖尿病给全球各国的医疗保健系统带来了越来越大的经济负担。需要采取更多的预防措施来减轻这一负担。同时,贫困国家的人均支出非常低,表明需要在这些环境中投入更多资源来提供基本的糖尿病护理。

相似文献

1
Global healthcare expenditure on diabetes for 2010 and 2030.2010 年和 2030 年全球糖尿病医疗支出。
Diabetes Res Clin Pract. 2010 Mar;87(3):293-301. doi: 10.1016/j.diabres.2010.01.026. Epub 2010 Feb 19.
2
IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes.国际糖尿病联盟《糖尿病地图集》对2014年全球糖尿病医疗支出的估计。
Diabetes Res Clin Pract. 2016 Jul;117:48-54. doi: 10.1016/j.diabres.2016.04.016. Epub 2016 Apr 27.
3
Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.全球及各区域糖尿病相关卫生支出估计和预测:国际糖尿病联盟糖尿病地图集第 9 版结果。
Diabetes Res Clin Pract. 2020 Apr;162:108072. doi: 10.1016/j.diabres.2020.108072. Epub 2020 Feb 13.
4
Economic costs of diabetes in the US in 2002.2002年美国糖尿病的经济成本。
Diabetes Care. 2003 Mar;26(3):917-32. doi: 10.2337/diacare.26.3.917.
5
Economic Costs of Diabetes in the U.S. in 2017.2017 年美国糖尿病的经济成本。
Diabetes Care. 2018 May;41(5):917-928. doi: 10.2337/dci18-0007. Epub 2018 Mar 22.
6
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.全球卫生融资的过去、现在和未来:对 195 个国家 1995 年至 2050 年用于卫生的发展援助、政府、自付费用和其他私人支出的评估。
Lancet. 2019 Jun 1;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4. Epub 2019 Apr 25.
7
Economic costs of diabetes in the U.S. In 2007.2007年美国糖尿病的经济成本。
Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017.
8
National health expenditures: a global analysis.国家卫生支出:全球分析。
Bull World Health Organ. 1994;72(4):623-37.
9
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.追踪卫生和 COVID-19 方面的发展援助:对 204 个国家和地区 1990-2050 年的卫生方面的发展援助、政府、自付费用和其他私人支出的审查。
Lancet. 2021 Oct 9;398(10308):1317-1343. doi: 10.1016/S0140-6736(21)01258-7. Epub 2021 Sep 22.
10
Economic costs of diabetes in the U.S. in 2012.2012 年美国糖尿病的经济成本。
Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6.

引用本文的文献

1
Efficacy and Safety of Femtosecond Laser-Assisted Cataract Surgery with the Catalys Platform in Patients with Type 2 Diabetes and Cataract: A Prospective Cohort Study.使用Catalys平台的飞秒激光辅助白内障手术治疗2型糖尿病合并白内障患者的疗效与安全性:一项前瞻性队列研究
Ophthalmol Ther. 2025 Sep;14(9):2301-2312. doi: 10.1007/s40123-025-01218-8. Epub 2025 Jul 29.
2
The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in China.基于中国一项真实世界研究的糖尿病性周围神经病理性疼痛患者的经济负担
Clinicoecon Outcomes Res. 2025 Jun 13;17:437-446. doi: 10.2147/CEOR.S501243. eCollection 2025.
3
Therapeutic Potential of Infrared and Related Light Therapies in Metabolic Diseases.
红外线及相关光疗法在代谢性疾病中的治疗潜力
Int J Mol Sci. 2025 May 27;26(11):5134. doi: 10.3390/ijms26115134.
4
Evidence based prevalence of diabetes related depression in Kohat, Pakistan: a cross-sectional study.巴基斯坦科哈特地区糖尿病相关抑郁症的循证患病率:一项横断面研究。
BMC Public Health. 2025 May 26;25(1):1938. doi: 10.1186/s12889-025-23151-y.
5
Association between the plasma atherogenic index and type 2 diabetes in Chinese population: prospective cohort study based on 4C study.中国人群血浆致动脉粥样硬化指数与2型糖尿病的关联:基于4C研究的前瞻性队列研究
Front Endocrinol (Lausanne). 2025 Apr 16;16:1571602. doi: 10.3389/fendo.2025.1571602. eCollection 2025.
6
Impact of Pharmacist Educational Intervention on Costs of Medication with Improved Clinical Outcomes for Diabetic Patients in Various Tertiary Care Hospitals in Malaysia: A Randomized Controlled Trial.药剂师教育干预对马来西亚各三级护理医院糖尿病患者药物治疗费用及临床结局改善的影响:一项随机对照试验
Healthcare (Basel). 2025 Apr 14;13(8):901. doi: 10.3390/healthcare13080901.
7
Diabetes: Non-Invasive Blood Glucose Monitoring Using Federated Learning with Biosensor Signals.糖尿病:使用联合学习与生物传感器信号进行无创血糖监测
Biosensors (Basel). 2025 Apr 16;15(4):255. doi: 10.3390/bios15040255.
8
Mediterranean diet and diabetic microvascular complications: a systematic review and meta-analysis.地中海饮食与糖尿病微血管并发症:一项系统评价与荟萃分析
BMC Nutr. 2025 Apr 2;11(1):66. doi: 10.1186/s40795-025-01038-w.
9
Monitoring microvascular changes over time with a repositionable 3D ultrasonic capacitive micromachined row-column sensor.使用可重新定位的3D超声电容微机械行列传感器随时间监测微血管变化。
Sci Adv. 2025 Mar 28;11(13):eadr6449. doi: 10.1126/sciadv.adr6449. Epub 2025 Mar 26.
10
[Factors Associated with Diabetes Mellitus Screening in Peruvian Population: A public health problem?Fatores associados a triagem da Diabetes Mellitus na populado Peruana: um problema de saúde pública?].[秘鲁人群中与糖尿病筛查相关的因素:一个公共卫生问题?秘鲁人群中与糖尿病筛查相关的因素:一个公共卫生问题?]
Rev Cuid. 2023 May 28;14(1):e17. doi: 10.15649/cuidarte.2792. eCollection 2023 Jan-Apr.